[1]
Millar, A.C., Elterman, D.S., Goldenberg, L., Van Asseldonk, B., Curtis, A. and Jarvi, K. 2016. A survey of Canadian urologists’ opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer. Canadian Urological Association Journal. 10, 5-6 (Jun. 2016), 181–4. DOI:https://doi.org/10.5489/cuaj.3608.